United States
Germany
Japan
United Kingdom
China
FCER2 mouse monoclonal antibody, clone OTI2B6 (formerly 2B6)
| Applications | FC, IHC, WB |
| Reactivities | Human |
Antibodies
FCER2 mouse monoclonal antibody, clone OTI7C9 (formerly 7C9)
| Applications | FC, IHC, WB |
| Reactivities | Human |
FCER2 mouse monoclonal antibody, clone OTI1E5 (formerly 1E5)
| Applications | FC, WB |
| Reactivities | Human |
FCER2 mouse monoclonal antibody, clone OTI9B6 (formerly 9B6)
| Applications | FC, WB |
| Reactivities | Human |
FCER2 mouse monoclonal antibody, clone OTI3A2 (formerly 3A2)
| Applications | IHC, WB |
| Reactivities | Human |
FCER2 mouse monoclonal antibody, clone OTI6C2 (formerly 6C2)
| Applications | IHC, WB |
| Reactivities | Human |
FCER2 mouse monoclonal antibody, clone OTI2H2 (formerly 2H2)
| Applications | IHC, WB |
| Reactivities | Human |
FCER2 mouse monoclonal antibody, clone OTI2B6 (formerly 2B6)
| Applications | FC, IHC, WB |
| Reactivities | Human |
FCER2 mouse monoclonal antibody, clone OTI9B6 (formerly 9B6)
| Applications | FC, WB |
| Reactivities | Human |
FCER2 mouse monoclonal antibody, clone OTI1E5 (formerly 1E5)
| Applications | FC, WB |
| Reactivities | Human |
FCER2 mouse monoclonal antibody, clone OTI7C9 (formerly 7C9)
| Applications | FC, IHC, WB |
| Reactivities | Human |
FCER2 mouse monoclonal antibody, clone OTI6C2 (formerly 6C2)
| Applications | IHC, WB |
| Reactivities | Human |
FCER2 mouse monoclonal antibody, clone OTI3A2 (formerly 3A2)
| Applications | IHC, WB |
| Reactivities | Human |
FCER2 mouse monoclonal antibody, clone OTI2H2 (formerly 2H2)
| Applications | IHC, WB |
| Reactivities | Human |
